Abstract. The effects of androgen and epidermal growth factor (EGF) on cell proliferation and the expression of mRNA and protein of androgen receptor (AR) were examined in an androgen-sensitive human prostatic cancer cell line, LNCaP, by Northern and Western blot analyses. The addition of 1 nM dihydrotestosterone (DHT), at which the proliferation of the cells was most stimulated, did not change the level of AR mRNA but increased the level of AR protein by reducing the turnover rate of the AR protein. EGF also stimulated the proliferation of the cells but repressed the expression of AR mRNA and protein. This repression was found to be exerted primarily at the level of transcription. When DHT and EGF were added simultaneously to the cells, the level of AR mRNA was reduced to the same degree as was accomplished by the addition of EGF alone. On the other hand, the level of AR protein increased but this increase was about 70% of that attained following the addition of DHT alone. The stimulatory effects of EGF and DHT on cell proliferation were found to be additive. These results indicate that EGF down-regulates the level of AR mRNA and thereby also that of AR protein irrespective of the presence of DHT, and that EGF stimulates the proliferation of LNCaP cells through a different pathway from that of DHT.
THE GROWTH
of prostatic cancer is generally dependent on androgen, and therefore when anti-androgen treatment is given the growth rate of prostatic cancer is decreased [1, 2] . However, in 20% of patients, prostatic cancers hardly respond to anti-androgen therapy.
In these cancers, a decrease in androgen receptor (AR) has been reported as revealed by steroid-binding assay [3] [4] [5] [6] . A decrease in AR has also been observed in poorly differentiated prostatic cancers [7, 8] . Coincidentally, in poorly differentiated prostatic cancers, it has been reported that decreased expression of AR protein is accompanied by increased expression of epidermal growth factor receptor (EGFR) [9] . In breast cancers, it is known that the presence of estrogen receptor (ER) is a prerequisite for successful endocrine therapy and that ER-negative tumors are associated with a poor prognosis [10, 11] . By ligand-binding assay and immunohistochemical staining, an inverse relationship has been demonstrated between the levels of ER and EGF. [12, 13] . Furthermore, an in vitro study demonstrated that EGF repressed the expression of ER in a human breast cancer cell line, MCF-7 [14] . These observations suggest that EGF plays an important role in the disappearance of ER in breast cancer cells. It is therefore likely that EGF is also involved in the disappearance of AR in prostatic cancer 
Results

DetPction of AR mRNA and protein in LNCaP
Northern blot hybridization with RNA from LNCaP cells revealed the presence of two mRNA species as reported by Trapman et al. [23] , being about 11 kb and 8 kb as major and minor bands, respectively, as shown in Fig. 1A . The intensities of these two bands changed in the same manner throughout the present experiments (data not shown). In-the following experiments, the amounts of AR mRNA were expressed by the intensities of 11 kb bands after normalization .
As shown in Fig. 1B Effect of DHT on the levels of AR mRNA and protein
As shown in Fig. 2A , when LNCaP cells were cultured in the presence of 1nM DHT, at which the proliferation of LNCaP was most stimulated (data not shown), no change was observed in the level of AR mRNA. But when cells were cultured in the absence of DHT, the level of AR mRNA increased gradually to about 150% in 48 h. A similar observation has been reported in rat prostate cells [16] . In contrast with the change in AR mRNA, the level of AR protein increased by 200% in a 12 h culture in the presence of DHT, while in the absence of DHT no change was observed in the level of AR protein (Fig. 2B) . After 12 h of incubation with DHT, the level of AR protein went down. This was probably due to the decrease in DHT due to metabolization or degradation in the culture medium since the amount of AR protein was kept at about double when the culture was supplemented with DHT every 12 h (Fig. 2B , dash line). Thus DHT increased AR protein without changing the level of AR mRNA.
To determine whether this regulation is exerted at the level of translation or post-translation, pulse-chase experiments were carried out. The half-life in the absence or presence of DHT was determined to be approximately 3.3 h or 7.5 h, respectively, as shown in Fig. 2C . Although this increase to twice in the half-life of AR protein could account for the increase in AR protein, we further examined whether DHT influences the rate of AR protein synthesis. AR proteins were labeled for 30 min, during which the decay of AR proteins was small enough to be considered negligible. As shown in Fig. 2D , no difference was observed in the amounts of newly synthesized AR protein in the presence or absence of DHT. These results indicate that DHT does not affect either transcription or translation of AR mRNA but increases AR protein by reducing its turnover rate at a post-translational level.
Effect of EGF on the proliferation and the level of AR inRN A and protein in LNCaP cells
Since 50 ng/ml EGF stimulated the proliferation of LNCaP cells to the same degree as was accomplished by DHT as shown in Fig. 3 , we next analyzed the effect of EGF on the level of AR protein. Unlike DHT, 5 or 50ng/m1 EGF decreased AR protein to approximately 30 or 20% of the control in 24 h, respectively (Fig. 4) . To determine how the effect of EGF was exerted on the AR protein level, we first examined the turnover rate of AR protein in the presence of in AR protein in the presence of EGF, suggesting that another step(s) might also be involved. Then the change in the level of AR mRNA upon the addition of EGF was examined. As revealed in Fig.  5A , EGF down-regulated the level of AR mRNA by 40-50% of the control in 24 h. To distinguish whether the down-regulation was exerted at the level of transcription or post-transcription, the turnover rates of AR mRNA were compared in the presence and absence of EGF with actinomycin D. Fig. 5B showed that the half-life of AR mRNA was unchanged, which was approximately 6.5 h, irrespective of the presence of EGF. Taken together, these results indicate that EGF downregulates the steady state level of AR protein primarily by inhibiting the transcription of AR mRNA and secondly by stimulating the decay of AR protein.
Effect of simultaneous addition of DHT and EGF on the level of AR protein
Since it is expected that prostate cells in vivo are provided with androgen, EGF should act on prostate cells in the presence of androgen. We therefore examined the effects of EGF in the presence of androgen. The stimulatory effects of these reagents on the proliferation of ENCaP cells were found to be additive as shown in Fig. 3 . Since the enhanced growth rate in the presence of DHT and EGF was not able to be achieved by DHT alone, EGF appears to stimulate the proliferation of the cells via different pathway from that of DHT. Next, the level of AR mRNA and protein were examined in the presence of both EGF and DHT at 12 h when the stimulatory effect of DHT on the level of AR protein is maximum. As shown in Fig. 6A , irrespective of the presence of DHT, 5 or 50ng/ml EGF decreased the level of AR mRNA to about 60 or 50% of the control, respectively. This result indicated that the effect of EGF on the level of AR mRNA was not influenced by DHT.
As mentioned previously, DHT up-regulates the level of AR protein by reducing its turnover rate. However, when DHT and EGF was simultaneously added, the AR protein level was reduced to 67 to 77% of the control with DHT alone at 12 h of culture (Fig. 6B) In addition, it has been demonstrated that AR protein is phosphorylated in the nucleus [26] . The binding of ligand and/or phosphorylation of AR may result in a structural change in AR protein, which in turn may stabilize the protein. However, it should be noted that in contrast with AR, glucocorticoid receptor (GR) is down-regulated by its own ligand both at transcriptional and at post-translational levels [27, 28] , though GR belongs to the same class as AR among the subgroups of steroid hormone receptor gene family and shares common responsive elements with AR [16, [29] [30] [31] . In spite of several similarities between AR and GR, each regulatory mechanism for the expression appears quite different. EGF had a negative effect on the steady-state level of AR protein primarily by inhibiting the transcription of AR gene. There are several genes whose expressions are regulated by EGF at the transcriptional level [32] [33] [34] [35] . In some of those genes, such as prolactin and VL30 genes, activation of protein kinase C is involved in the regulatory pathway of the expression [32, 33] . In the present case, however, the possibility that activation of protein kinase C is involved in the downregulation of transcription of AR gene by EGF could be ruled out, since the addition of 12-0-tetradecanoyl phorbol acetate which is known to activate protein kinase C did not result in a decrease in the level of AR mRNA (our unpublished observation).
To understand the mechanism of down-regulation of the transcription of AR gene by EGF, it will be necessary to identify the regulatory elements of transcription of the AR gene.
The negative effects of EGF appeared to be uninfluenced by DHT. When two reagents were added to the cells simultaneously, the level of AR mRNA was reduced to the same degree as following the addition of EGF alone. The increase in the level of AR protein due to DHT was found to be counteracted by EGF (Fig. 6B) . Considering the kinetics of down-regulation of the level of AR mRNA by EGF (Fig. 5B) and assuming that the effect of DHT stabilizing AR protein is unchanged following the addition of EGF, this counteraction can be reasonably explained by the sum of the reduction of the amount of AR mRNA in 12h and the extended half-life of the AR protein. It appears that the primary effects of DHT and EGF are exerted at different levels without being influenced by the other. In summary, the results obtained in this work demonstrated the potency of EGF that represses the expression of AR protein in a prostatic cancer cell line. In the light of the observation that increased expression of EGFR is accompanied by decreased expression of AR protein in poorly differentiated prostatic cancers [9] , our in vitro study suggests that the loss of ARs in such cancers could be due to the effect of EGF. Therefore, to investigate the mechanisms for repression of the transcription of AR gene by EGF and for the increase in EGFR is a subject for further research.
